Trial intelligence / Profile preview

Lorazepam Routes for Acute Convulsions in Children (BIVIN)

NCT00343096Phase 3Terminated

Start
Jun 2006
Primary completion
Mar 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of lorazepam in status epilepticus (SE), epilepsy. Started Jun 2006; status: terminated.

02

Drugs

lorazepam
03

Conditions

status epilepticus (SE)epilepsy

Beyond the preview

Go deeper on NCT00343096.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00343096.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call